UNSPSC 51201811: Thalidomide

This classification denotes an indole compound and immunosuppressant with the molecular formula C13H10N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4Z8R6ORS6L, chemically known as 2,6-dioxo-3-phthalimidopiperidine but generally known as thalidomide, which bears US NIH Compound Identifier 5426. European Medicines Agency schedules Thalidomide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10958MIG.

UNSPSC 51201811 Thalidomide is a Commodity code for pharmaceutical products, but the recent state and local procurement activity under this code shows a mismatch: the sole documented opportunity involves a Yellow Fever Vaccine procurement rather than thalidomide itself. The Mississippi State Department of Health posted a sole source notice on July 13, 2026 for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026. This suggests the code may be used by state health agencies to classify vaccine and immunization procurement more broadly, or the categorization reflects a data-entry error in the underlying procurement system. State and local activity under this code appears limited in scope and frequency based on available recent opportunities.

The sole documented opportunity originates from Mississippi, a state health department, reflecting the typical customer for vaccine procurement under this code tier. The notice is not a competitive RFP or IFB but rather a sole source publication inviting objections to single-source classification, a procedural step that precedes either competitive bidding or appeal to the Public Procurement Review Board if alternative sources are substantiated. The notice does not disclose contract value, quantity, or term. Without additional recent opportunities posted under this Commodity code across other jurisdictions or time periods, geographic spread and competitive activity levels cannot be characterized. Firms evaluating this code should verify with state procurement offices whether thalidomide or other pharmaceutical products are regularly solicited under 51201811, as current data suggests limited or misclassified activity.